Experimental group:Anti-ILT3 CAR-T cells

2 trials

Sponsors

Zhejiang Provincal People's Hospital

Conditions

Acute myeloid leukemia (M4/M5)

Early Phase 1

Clinical study of autologous T cells modified with ILT3 chimeric antigen receptor for relapsed/refractory acute myeloid leukemia (M4/M5)

RecruitingChiCTR2100044169

Zhejiang Provincal People's HospitalAcute myeloid leukemia (M4/M5)

Start: 2021-03-01Updated: 2021-08-30

Clinical study of autologous T cells modified with ILT3 chimeric antigen receptor for relapsed/refractory acute myeloid leukemia (M4/M5)

RecruitingChiCTR2100044163

Zhejiang Provincal People's HospitalAcute myeloid leukemia (M4/M5)

Start: 2021-03-03Updated: 2021-08-30